MANILA, Philippines — The Philippines has forced a movement limitation on four different nations as it refreshed its "red rundown" powerful September 19, Malacañang reported Friday.
In an assertion, official representative Harry Roque said those additional in the red rundown or regions considered high-hazard for COVID-19 are Grenada, Papua New Guinea, Serbia, and Slovenia. Travel control on these four nations will be until September 30.
As per past rules gave by the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF), inbound explorers coming from nations under the red rundown are denied from entering the country, paying little heed to their inoculation status.
In the meantime, beneath are the 52 nations and domains where thoroughly inoculated voyagers fit the bill for seven-day office-based isolate rather than ten days:
American Samoa
Burkina Faso
Cameroon
Cayman Islands
Chad
China
Comoros
Republic of the Congo
Djibouti
Central Guinea
Falkland Islands (Malvinas)
Gabon
Hong Kong
Hungary
Madagascar
Mali
Unified States of Micronesia
Montserrat
New Caledonia
New Zealand
Niger
Northern Mariana Islands
Palau
Poland
Saba (Special Municipality of the Kingdom of Netherlands)
Holy person, Pierre, and Miquelon
Sierra Leone
Sint Eustatius
Taiwan
Algeria
Bhutan
Cook Islands
Eritrea
Kiribati
Marshall Islands
Nauru
Nicaragua
Niue
North Korea
Holy person Helena
Samoa
Solomon Islands
Sudan
Syria
Tajikstan
Tanzania
Tokelau
Tonga
Turkmenistan
Tuvalu
Vanuatu
Yemen
Roque said that "any remaining nations/regions/wards not referenced are in the Yellow List."
Inbound explorers from those in the yellow rundown or regions that are moderate-hazard for COVID-19 should go through a 14-day isolate made out of a 10-day office-based isolate and a four-day home isolate.
On the seventh day of seclusion, they will go through RT-PCR and finish the 10-day office-based isolate regardless of whether they get a negative test outcome.
DOH: Ivermectin still not for COVID-19 treatment
The antiparasitic drug ivermectin is as yet not suggested as a treatment for COVID-19, the Department of Health (DOH) repeated Friday.
DOH Undersecretary Ma. Rosario Vergeire said this after the British Ivermectin Research Development (BIRD) sent a letter requesting the Philippine government to embrace the utilization of ivermectin for the early treatment of COVID-19.
Vergeire said the DOH reacted to the said letter and emphasized that ivermectin is not suggested for COVID-19 treatment, referring to the most recent examination.
"Because of the current proof from randomized controlled preliminaries, we don't suggest the utilization of ivermectin for the treatment of COVID-19. It has not demonstrated to diminish mortality fundamentally, nor to work on other clinical results," Vergeire said while perusing the DOH's reaction letter to the BIRD.
"At present, the clinical agreement is that there is no proof to help the utilization of ivermectin in treating COVID-19. While the DOH isn't against the utilization of investigational drugs, we underscore that in utilizing items being scrutinized, the wellbeing of each Filipino should take most extreme priority," she added.
Vergeire said their proposal would be refreshed as more proof is created from the continuous ivermectin preliminaries.
"We should consistently put the security of Filipinos first before showing the utilization of meds in the country. So have confidence that the DOH and FDA (Food and Drug Administration) are at the bleeding edge of guaranteeing COVID-19 medications and prescriptions are protected, successful, available, and moderate for use," Vergeire said.
"Here in the Philippines, we don't have any endorsed prophylactic medications for COVID-19," she added.
Vergeire reminded the public that the "most ideal approach to ensure ourselves" until further notice is to remain sound, consistently practice the base general wellbeing principles, and get inoculated.
Two individuals from the House of Representatives asked the Supreme Court on Thursday to urge the DOH and the FDA to give an authentication of item enrollment and permit to work to organizations occupied with the assembling and disseminating ivermectin as a treatment for COVID-19.
You must be logged in to post a comment.